Endoscopic ultrasound-guided radiofrequency ablation of pancreatic neuroendocrine tumors: a case series
Open Access
- 17 November 2020
- journal article
- review article
- Published by Georg Thieme Verlag KG in Endoscopy International Open
- Vol. 08 (12) , E1754-E1758
Abstract
Background and study aims Surgery is the considered the therapeutic cornerstone for pancreatic neuroendocrine tumors (P-NETs), although burdened by high risk of significant adverse events. Recently, endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) has been described for P-NETs. We aimed to evaluate the effectiveness and safety of EUS-RFA for treatment of P-NETs. Patients and methods We prospectively included all consecutive patients with P-NET ≤ 20 mm who were treated with EUS-RFA and were followed-up for at least 12 months. Results Ten patients (5 males, mean age 78.6 years, mean body mass index 28.2) with 11 P-NETs (mean size 14.5 mm; range 9 – 20 mm) localized in the pancreatic head (3 lesions), pancreatic body (5 lesions), and tail (3 lesions) underwent complete EUS ablation with one session of RFA. Complete ablation of P-NET was reached using a single-session RFA with a mean of 2.3 treatment applications per session. At both 6 – and 12-months computed tomography scans, all the patients had complete disappearance of lesions with radiological normalization. Regarding safety, only two cases of mild abdominal pain were recorded in two subjects with pancreatic head lesion, which were effectively treated with analgesics. The mean duration of hospital stay was 4 days (range 3 – 7 days). Conclusions EUS-RFA is effective and safe in treating P-NETs. It may be considered an effective therapeutic option in the treatment of small P-NETs independently from their functional status.Keywords
This publication has 21 references indexed in Scilit:
- EUS-guided radiofrequency ablation for management of pancreatic insulinoma by using a novel needle electrode (with videos)Gastrointestinal Endoscopy, 2016
- Endoscopic ultrasound guided radiofrequency ablation, for pancreatic cystic neoplasms and neuroendocrine tumorsWorld Journal of Gastrointestinal Surgery, 2015
- Exploring the rising incidence of neuroendocrine tumors: A population‐based analysis of epidemiology, metastatic presentation, and outcomesCancer, 2014
- Endoscopic ultrasound-guided placement of plastic vs. biflanged metal stents for therapy of walled-off necrosis: a retrospective single-center seriesEndoscopy, 2014
- Radiofrequency Ablation of Pancreatic Neuroendocrine TumorsPancreas, 2014
- The Incidental Asymptomatic Pancreatic Lesion: Nuisance or Threat?Journal of Gastrointestinal Surgery, 2009
- Pancreatic neuroendocrine tumorsCancer, 2009
- Changing Incidence of Pancreatic NeoplasmsPancreas, 2008
- One Hundred Years After “Carcinoid”: Epidemiology of and Prognostic Factors for Neuroendocrine Tumors in 35,825 Cases in the United StatesJournal of Clinical Oncology, 2008
- Pancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumorsEndocrine-Related Cancer, 2008